Consolidated Statements of Changes in Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2023		17,564,182
Balance at beginning of period at Dec. 31, 2023	$ 254,935	$ 17,564	$ 168,614	$ 124,400	$ (55,643)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income	1,289				1,289
Dividends on common shares	(1,975)			(1,975)
Issuance of restricted stock, net of forfeitures (in shares)		(594)
Issuance of restricted stock, net of forfeitures	0
Tax withholding related to vesting of restricted stock (in shares)		(4,977)
Tax withholding related to vesting of restricted stock	(66)	$ (5)	(61)
Stock-based compensation expense	398		398
Net income	5,333			5,333
Balance at end of period (in shares) at Mar. 31, 2024		17,558,611
Balance at end of period at Mar. 31, 2024	$ 259,914	$ 17,559	168,951	127,758	(54,354)
Balance at beginning of period (in shares) at Dec. 31, 2024	17,519,884	17,519,884
Balance at beginning of period at Dec. 31, 2024	$ 278,675	$ 17,520	168,353	140,369	(47,567)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income	4,167				4,167
Dividends on common shares	(2,015)			(2,015)
Issuance of restricted stock, net of forfeitures (in shares)		4,880
Issuance of restricted stock, net of forfeitures	0	$ 5	(5)
Tax withholding related to vesting of restricted stock (in shares)		(4,748)
Tax withholding related to vesting of restricted stock	(77)	$ (5)	(72)
Repurchase and retirement of shares (in shares)		(38,307)
Repurchase and retirement of shares	(630)	$ (38)	(592)
Stock-based compensation expense	192		192
Net income	$ 6,613			6,613
Balance at end of period (in shares) at Mar. 31, 2025	17,481,709	17,481,709
Balance at end of period at Mar. 31, 2025	$ 286,925	$ 17,482	$ 167,876	$ 144,967	$ (43,400)